The key to a successful program of investigator supported studies is maintaining productive relationships with the physicians at the clinical sites. With unique protocol requirements and widely different levels of clinical trial experience, the investigator supported sites placed huge demands on the pharmaceutical company’s clinical supplies team. Instead of focusing on their multiple Phase III studies, their clinical supplies team found themselves distracted by the demands of numerous clinical trial units testing multiple compounds. Read this case study to learn how their on-time shipments have exceeded 90%, with the delays limited exclusively to holiday periods. And in no instance has a patient failed to get drug due to a supply shortage.